July 25, 2017 9:52 PM ET

Biotechnology

Company Overview of Caladrius Biosciences, Inc.

Executive Profile

Arshed A. Quyyumi M.D., FRCP, FACC

Member of Cardiovascular Disease Scientific Advisory Board, Caladrius Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Arshed A. Quyyumi, also known as Ali, M.D., FRCP, FACC, has been a Professor of Medicine in the Division of Cardiology at Emory University School of Medicine since 2001. Dr. Quyyumi serves as Co-Director, Emory Clinical Cardiovascular Research Institute (ECCRI) and Emory Cardiovascular Research. From 1986 to 2001, he served in several capacities at the National Institutes of Health in Bethesda, MD, including: chief resident of cardiology, Senior Investigator, and ...

Corporate Headquarters

106 Allen Road
Basking Ridge, New Jersey 07920

United States

Phone: 908-842-0100
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Xiaochun Xu Chairman of Board and Interim Chief Executive Officer
Cesca Therapeutics Inc.
--
Marc H. Hedrick M.D.Chief Executive Officer, President & Director
Cytori Therapeutics, Inc.
$450.0K
Michael Tomas Chief Executive Officer, President, Chief Financial Officer and Director
U.S. Stem Cell, Inc.
$1.2M
Andrey Semechkin Ph.D.Co-Chairman & Chief Executive Officer
International Stem Cell Corporation
$143.1K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$496.0K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Caladrius Biosciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.